Plandai Biotechnology, Inc. New Products to Hit the Market With Higher Absorption Rate

NEW YORK, NY--(Marketwired - May 14, 2013) - In a series of articles, Stock House Group, a research and content development investment relations firm, will lay out Plandaí Biotechnology, Inc.'s (OTCQB: PLPL) three new products all being individually labeled and branded under the Phytofare™ name. In addition to the products, the patented extraction process the company will use to bring customers its healthy lineup of extracts will also be highlighted. This installment will focus on the first of the three, highly bioavailable extracts -- Phytofare™ Catechin Extract.

Phytofare™ Catechin Extract ("PCE") is a natural flavonoid rich in phenols and antioxidants. Catechins are chemical compounds essential to boosting the immune system, lowering cholesterol, fighting obesity, and aiding in the prevention of cancers, malaria, and many other parasitic and viral infections.

Phytofare™ PCE is a 65 percent polyphenol extract containing 85-88 percent catechins through the release of the active and stable immature catechin precursors from the green tea leaf. Phytonutrients, particularly catechins derived from green tea and its components, have been thoroughly researched (over 200 published scientific papers) and shown to have anti-viral and anti-inflammatory properties.

Most green tea extracts are made from dried unfermented tea leaf -- meaning that the antioxidants have been compromised in stability and activity. However, Phytofare™ PCE is recovered from live plant material, retaining the catechins in an active and stable form.

Plandaí Biotechnology will bring to the market a scientifically improved, more bioavailable line of products. To accomplish this, Plandaí will put on its lab coats and employ a patented extraction process that allows this biotech to beat its competition. This process begins with the first product the company will bring to market, Phytofare™ Catechin Extract.

Continue reading this article at www.stockhousegroup.com/features.

About Stock House Group
Stock House Group is a full service Investment Relations firm specializing in Awareness, Research, and Content Development. The firm offers a platform that allows CEOs to tell their story through the press with Feature Articles, Research Reports, and CEO Interviews. At the same time, Stock House Group is building a library of Research for Investors to use that allows them to get more informed on small cap stocks. For more information visit Stock House Group at www.stockhousegroup.com.